膳食钾摄入与慢性肾脏病患者高钾血症是否相关?
本研究横断面分析非透析慢性肾脏病(NDD-CKD)和血液透析(HD)队列,用3天饮食记录评估膳食钾摄入。结果显示两个队列中膳食钾与血钾或高钾血症均无关联,糖尿病和代谢性酸中毒等临床因素与高钾血症相关。
要点
- NDD-CKD和HD患者中膳食钾摄入与血钾无关联。
- 高钾血症相关因素包括糖尿病和代谢性酸中毒。
- 限制膳食钾前应仔细评估实际摄入并考虑其他临床因素。
核心结论
- 在NDD-CKD和HD患者中,膳食钾摄入与血钾或高钾血症均无关联。
- 管理高钾血症时应先评估患者钾摄入并考虑其他影响血钾平衡的临床因素。
研究设计与样本
- 横断面分析,包括NDD-CKD队列95例和HD队列117例。
- 膳食钾通过3天饮食记录评估,排除能量摄入低于静息能量消耗的低报者。
- 高钾血症定义为血清钾>5.0 mEq/L。
主要发现
- NDD-CKD中高钾血症占36.8%,HD中占50.5%。
- NDD-CKD中血钾与膳食钾无关联(r=0.01;P=0.98),与所选食物组也无关联。
- NDD-CKD多变量分析中与高钾血症相关的因素为糖尿病(OR 3.55,95%CI 1.07-11.72)和代谢性酸中毒(OR 4.35,95%CI 1.37-13.78)。
- HD中血钾与钾摄入无关联(r=-0.06,P=0.46),与食物组也无关联。
- HD多变量分析中高钾血症的预测因素为糖尿病(OR 4.22,95%CI 1.31-13.6)和血清肌酐(OR 1.50,95%CI 1.24-1.81)。
临床怎么用
- 不应仅凭膳食钾摄入判断高钾血症风险。
- 限制膳食钾前应仔细评估患者实际钾摄入量。
- 管理高钾血症时应综合考虑糖尿病、代谢性酸中毒等临床因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dietary potassium restriction is a strategy to control hyperkalemia in chronic kidney disease (CKD). However, hyperkalemia may result from a combination of clinical conditions. This study aimed to investigate whether dietary potassium or the intake of certain food groups associate with serum potassium in the face of other risk factors. METHODS: We performed a cross-sectional analysis including a nondialysis-dependent CKD (NDD-CKD) cohort and a hemodialysis (HD) cohort. Dietary potassium intake was assessed by 3-day food records. Underreporters with energy intake lower than resting energy expenditure were excluded. Hyperkalemia was defined as serum potassium >5.0 mEq/L. RESULTS: The NDD-CKD cohort included 95 patients {median age 67 [interquartile range (IQR) 55-73] years, 32% with diabetes mellitus (DM), median estimated glomerular filtration rate 23 [IQR 18-29] mL/min/1.73 m2} and the HD cohort included 117 patients [median age 39 (IQR 18-67) years, 50% with DM]. In NDD-CKD, patients with hyperkalemia (36.8%) exhibited lower serum bicarbonate and a tendency for higher serum creatinine, a higher proportion of DM and the use of renin-angiotensin-aldosterone system blockers, but lower use of sodium bicarbonate supplements. No association was found between serum and dietary potassium (r = 0.01; P = 0.98) or selected food groups. Conditions associated with hyperkalemia in multivariable analysis were DM {odds ratio [OR] 3.55 [95% confidence interval (CI) 1.07-11.72]} and metabolic acidosis [OR 4.35 (95% CI 1.37-13.78)]. In HD, patients with hyperkalemia (50.5%) exhibited higher serum creatinine and blood urea nitrogen and lower malnutrition inflammation score and a tendency for higher dialysis vintage and body mass index. No association was found between serum and potassium intake (r = -0.06, P = 0.46) or food groups. DM [OR 4.22 (95% CI 1.31-13.6)] and serum creatinine [OR 1.50 (95% CI 1.24-1.81)] were predictors of hyperkalemia in multivariable analyses. CONCLUSIONS: Dietary potassium was not associated with serum potassium or hyperkalemia in either NDD-CKD or HD patients. Before restricting dietary potassium, the patient's intake of potassium should be carefully evaluated and other potential clinical factors related to serum potassium balance should be considered in the management of hyperkalemia in CKD.
引用
- Ramos CI, González-Ortiz A, Espinosa-Cuevas A, et al. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2021. PMID: 33247727. doi:10.1093/ndt/gfaa232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。